ROSELINE CAJUSTE: Open Payments
NPI 1760009104 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, COBENFY, UZEDY, FANAPT.
Industry payments across FL — which companies pay providers there.
